This review highlights hydrogel-based intra-articular drug delivery systems for rheumatoid arthritis, emphasizing their therapeutic potential and biocompatibility.
Key Points
Hydrogel-based injection systems improve drug delivery in rheumatoid arthritis, enhancing therapeutic effectiveness.
These systems can modulate inflammatory environments while protecting cartilage, addressing common treatment limitations.
The review details the cellular and molecular events in rheumatoid arthritis alongside hydrogel design principles.
Intra-articular administration with hydrogels presents a promising strategy to overcome systemic toxicity seen in conventional therapies.